Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2020-11-13 Notice of Dividend Amou…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
UPDATE ON THE PROPOSED DECLARATION AND PAYMENT OF SPECIAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the update on the proposed declaration and payment of a special dividend and the closure of the register of members. It references shareholder meetings, dividend payment dates, and register closure for dividend entitlement. The document is relatively short (3659 characters) and serves as an update or notice rather than a full financial report or detailed dividend report. It does not contain actual financial statements or detailed dividend analysis but rather informs shareholders about the dividend declaration and related procedural dates. Therefore, it fits the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2020-11-13 English
PROPOSED DECLARATION AND PAYMENT OF SPECIAL DIVIDEND
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the proposed declaration and payment of a special dividend. It references prior announcements and states that the Board has resolved to approve the declaration and payment of the special dividend, subject to shareholder approval and other conditions. The document does not contain detailed financial statements or comprehensive financial data but rather informs shareholders about the dividend proposal and upcoming details. The length is relatively short (2780 characters), and the content is focused on dividend declaration and payment details. Therefore, this document fits the category of a Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2020-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/10/2020. The content focuses on share capital changes, share options, and related securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, which aligns with disclosures about share capital changes rather than a full financial report or earnings release. The document is comprehensive and contains substantive data about share capital movements, not just an announcement or a brief summary. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA).
2020-11-03 English
WRITTEN RESOLUTIONS OF THE BOARD
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors regarding the circulation of written resolutions to consider and approve a special dividend. It mentions that a further announcement will be made with details if the dividend is approved. The document is short (1926 characters) and does not contain actual financial data or detailed dividend payment information, only a notice of intent and process. Therefore, it is not a full dividend notice but rather an announcement related to dividend declaration. This fits best with the category of Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories like Notice of Dividend Amount (DIV) which requires actual dividend details.
2020-10-27 English
VERY SUBSTANTIAL DISPOSAL - DISPOSAL OF CBPO SHARES AND PROPOSED PRIVATIZATION OF CBPO
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a very substantial disposal of shares and a proposed privatization involving share purchase agreements. It details the terms of the share sales, parties involved, conditions precedent, and the need for shareholder approval at an Extraordinary General Meeting (EGM). The document is lengthy (15,000 characters) and contains detailed transaction information, but it is primarily an announcement of the transaction and related shareholder meeting rather than a full financial report or regulatory filing. It does not contain financial statements or audit information, nor is it a transcript or presentation. The focus on the disposal and privatization, with detailed terms and conditions, fits best with a Capital/Financing Update (CAP) category, which covers updates on company fundraising, financing activities, or capital structure changes. Therefore, the document should be classified as CAP with high confidence.
2020-10-26 English
MAJOR TRANSACTION - DISPOSAL OF CBPO SHARES POST-COMPLETION ADJUSTMENT TO THE SALE PRICE
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a post-completion adjustment to the sale price related to a major transaction involving disposal of shares. It references previous announcements and a circular related to the transaction. The content focuses on the adjustment details and confirms that the transaction remains classified as a major transaction under the Listing Rules. There are no financial statements or detailed financial performance data presented, nor is this a full report or regulatory certification. The document is a specific transaction update announcement related to financing and capital structure changes. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 3522 characters, which is sufficient for a substantive announcement but not a full report.
2020-10-26 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.